Health Products

Pfizer Champix Product Recall (2021-06-08)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II

Summary

Product

A. Champix 0.5 mg tablets

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
00019062, 00020452, 00020451
Recalling Firm
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
Marketing Authorization Holder
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
B. Champix 0.5 / 1.0 mg tablet kitDIN 02298309KitVarenicline tartrate 0.5 mg
ED7397
Recalling Firm
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
Marketing Authorization Holder
Pfizer Canada ULC
17300 Trans-Canada Highway
Kirkland
H9J 2M5
Quebec
CANADA
A. Champix 0.5 mg tabletsDIN 02291177TabletVarenicline tartrate 0.5 mg 

Introduction

A. Champix 0.5 mg tablets

B. Champix 0.5 / 1.0 mg tablet kit

Reason

Presence of impurity N-nitrosovarenicline above the acceptable concentration limit in affected lot.  

Depth of distribution

Retailers 
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime